Endocyte receives $26M infusion from investors
West Lafayette-based Endocyte Inc. announced Friday that it has closed on $26 million in equity financing to help the company
continue developing cancer-fighting drugs.
West Lafayette-based Endocyte Inc. announced Friday that it has closed on $26 million in equity financing to help the company
continue developing cancer-fighting drugs.
Some of Indiana’s leading organizations in health information technology are collaborating on an effort to receive several
million dollars of stimulus funding.
This flu season looks to provide us an inkling of the real dangers inherent in large-scale health care reform, most especially
a full-blown national health care option.
The health insurance industry’s sudden counterpunch to the Senate version of health reform echoed in Indiana and
opened a key issue for the rest of the debate: Will covering half of the country’s uninsured mean raising premiums for
the 85 percent of Americans who already have insurance?
As health care legislation
continues to wend its way through Congress, Indianapolis-area industry leaders still harbor strong
opinions about the issue. Five industry insiders discussed how to improve the health care system during
IBJ’s Power Breakfast Sept. 25 at the Westin Indianapolis.
An ordinance that would prohibit lighting up in bars, bowling alleys and nightclubs, and nearby outdoor seating areas as well, was endorsed 4-2 by a City-County Council committee Wednesday night.
Doctors are considering their options as health care reform gains momentum.
Eli Lilly and Co. will sell its manufacturing plant in Lafayette to a German company in its first major move toward reducing its work force by 5,500 employees and cutting its operating expenses by $1 billion.
Specialists are clustering to focus on a single ailment, such as pain, to cut costs and improve quality of treatment.
Planned Parenthood of Indiana has cut 25 jobs and will close six health centers around the state as part of a restructuring
it attributed to a decline in federal funding.
Idaho is getting $13 million as part of a settlement reached with Indianapolis-based Eli Lilly and Co. over its marketing of
anti-psychotic drug Zyprexa.
Shares of Carmel-based life insurer soared as much as 26 percent, to $6.30 apiece, in morning trading after New York-based
Paulson & Co. agreed to buy $78 million in Conseco stock and $200 million in company bonds.
Nearly 700 workers will be offered severance, new jobs
Presenting five video excerpts from a free-wheeling panel discussion about health-care reform featuring five of the city’s
top minds and decision-makers. Reporter J.K. Wall moderates the IBJ’s Power Breakfast on Sept. 25, covering tort reform,illegal
immigrants, pay models and the role of insurance companies.
UnitedHealthcare has become the second health insurer to join Quality Health First, a pay-for-performance program operated
by the Indiana Health Information Exchange, the exchange announced Tuesday.
Presenting five video excerpts from a free-wheeling panel discussion about health-care reform featuring five of the city’s
top decision-makers. J.K. Wall moderates the IBJ’s Power Breakfast, covering tort reform,illegal immigrants, pay models and
insurance companies.
The insurance industry sharply escalated its criticism of the Senate health care bill Sunday, charging that the legislation
would shift costs to privately insured people, raising the price of a typical policy by hundreds, if not thousands, of dollars
annually.
Shares of WellPoint Inc. partially recovered Friday morning after a plunge was touched off Thursday by gathering momentum behind health care reform and talk of a windfall-profit tax by Speaker of the House Nancy Pelosi.
With a national unemployment rate of nearly 10 percent eroding its customer base, WellPoint Inc. is cutting at least 30
middle-management employees and reshuffling its corporate organization, according to internal memos obtained by IBJ.
The health reform bill sponsored by U.S. Sen. Max Baucus, D-Mont., would help pay for expanded health insurance coverage
by levying fees of $13 billion a year on the health care industry. The fees would deliver a hefty bill to just
about all of Indiana’s major health care companies. But how they’re reacting to the fees is all over the map.